ID   ELN_RAT                 Reviewed;         870 AA.
AC   Q99372; Q5RKH4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   24-JAN-2024, entry version 139.
DE   RecName: Full=Elastin;
DE   AltName: Full=Tropoelastin;
DE   Flags: Precursor;
GN   Name=Eln;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-870 (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Aorta;
RX   PubMed=1702999; DOI=10.1021/bi00493a024;
RA   Pierce R.A., Deak S.B., Stolle C.A., Boyd C.D.;
RT   "Heterogeneity of rat tropoelastin mRNA revealed by cDNA cloning.";
RL   Biochemistry 29:9677-9683(1990).
RN   [3]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2913947; DOI=10.1016/0003-9861(89)90322-6;
RA   Rich C.B., Foster J.A.;
RT   "Characterization of rat heart tropoelastin.";
RL   Arch. Biochem. Biophys. 268:551-558(1989).
RN   [4]
RP   PROTEIN SEQUENCE OF 28-37.
RX   PubMed=2768256; DOI=10.1016/s0021-9258(18)63819-0;
RA   Franzblau C., Pratt C.A., Faris B., Colannino N.M., Offner G.D.,
RA   Mogayzel P.J. Jr., Troxler R.F.;
RT   "Role of tropoelastin fragmentation in elastogenesis in rat smooth muscle
RT   cells.";
RL   J. Biol. Chem. 264:15115-15119(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 270-539 AND 564-870, AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1572637; DOI=10.1016/0888-7543(92)90289-5;
RA   Pierce R.A., Alatawi A., Deak S.B., Boyd C.D.;
RT   "Elements of the rat tropoelastin gene associated with alternative
RT   splicing.";
RL   Genomics 12:651-658(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 787-870.
RX   PubMed=2971041; DOI=10.1016/s0021-9258(18)68269-9;
RA   Deak S.B., Pierce R.A., Belsky S.A., Riley D.J., Boyd C.D.;
RT   "Rat tropoelastin is synthesized from a 3.5-kilobase mRNA.";
RL   J. Biol. Chem. 263:13504-13507(1988).
RN   [7]
RP   INDUCTION.
RX   PubMed=12882762; DOI=10.1152/ajplung.00180.2003;
RA   Liu J., Rich C.B., Buczek-Thomas J.A., Nugent M.A., Panchenko M.P.,
RA   Foster J.A.;
RT   "Heparin-binding EGF-like growth factor regulates elastin and FGF-2
RT   expression in pulmonary fibroblasts.";
RL   Am. J. Physiol. 285:L1106-L1115(2003).
RN   [8]
RP   CLEAVAGE OF SIGNAL PEPTIDE AFTER PRO-27, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=26479776; DOI=10.1021/acs.jproteome.5b00820;
RA   Tsuchiya T., Osaki T., Minamino N., Sasaki K.;
RT   "Peptidomics for studying limited proteolysis.";
RL   J. Proteome Res. 14:4921-4931(2015).
CC   -!- FUNCTION: Major structural protein of tissues such as aorta and nuchal
CC       ligament, which must expand rapidly and recover completely. Molecular
CC       determinant of the late arterial morphogenesis, stabilizing arterial
CC       structure by regulating proliferation and organization of vascular
CC       smooth muscle (By similarity). {ECO:0000250|UniProtKB:P54320}.
CC   -!- SUBUNIT: The polymeric elastin chains are cross-linked together into an
CC       extensible 3D network. Forms a ternary complex with BGN and MFAP2.
CC       Interacts with MFAP2 via divalent cations (calcium > magnesium >
CC       manganese) in a dose-dependent and saturating manner. Interacts with
CC       FBLN5 and FBN1. Forms a ternary complex with FBN1 and FBLN2 or FBLN5.
CC       Interacts with MFAP4 in a Ca (2+)-dependent manner; this interaction
CC       promotes ELN self-assembly (By similarity). Interacts with EFEMP2 with
CC       moderate affinity (By similarity). {ECO:0000250|UniProtKB:P04985,
CC       ECO:0000250|UniProtKB:P15502}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250|UniProtKB:P15502}. Note=Extracellular matrix of
CC       elastic fibers. {ECO:0000250|UniProtKB:P15502}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=1;
CC         IsoId=Q99372-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99372-2; Sequence=VSP_004244;
CC       Name=3;
CC         IsoId=Q99372-3; Sequence=VSP_004245;
CC       Name=4;
CC         IsoId=Q99372-4; Sequence=VSP_004246;
CC       Name=5;
CC         IsoId=Q99372-5; Sequence=VSP_004244, VSP_004245;
CC       Name=6;
CC         IsoId=Q99372-6; Sequence=VSP_004245, VSP_004246;
CC       Name=7;
CC         IsoId=Q99372-7; Sequence=VSP_004244, VSP_004246;
CC       Name=8;
CC         IsoId=Q99372-8; Sequence=VSP_004244, VSP_004245, VSP_004246;
CC   -!- INDUCTION: Down-regulated by DTR via activation of EGFR.
CC       {ECO:0000269|PubMed:12882762}.
CC   -!- PTM: Elastin is formed through the cross-linking of its soluble
CC       precursor tropoelastin. Cross-linking is initiated through the action
CC       of lysyl oxidase on exposed lysines to form allysine. Subsequent
CC       spontaneous condensation reactions with other allysine or unmodified
CC       lysine residues result in various bi-, tri-, and tetrafunctional cross-
CC       links. The most abundant cross-links in mature elastin fibers are
CC       lysinonorleucine, allysine aldol, desmosine, and isodesmosine.
CC   -!- PTM: Hydroxylation on proline residues within the sequence motif, GXPG,
CC       is most likely to be 4-hydroxy as this fits the requirement for 4-
CC       hydroxylation in vertebrates. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the elastin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085910; AAH85910.1; -; mRNA.
DR   EMBL; M60647; AAA42269.1; -; mRNA.
DR   EMBL; M86372; AAA42271.1; -; Genomic_DNA.
DR   EMBL; M86355; AAA42271.1; JOINED; Genomic_DNA.
DR   EMBL; M86363; AAA42271.1; JOINED; Genomic_DNA.
DR   EMBL; M86364; AAA42271.1; JOINED; Genomic_DNA.
DR   EMBL; M86366; AAA42271.1; JOINED; Genomic_DNA.
DR   EMBL; M86371; AAA42271.1; JOINED; Genomic_DNA.
DR   EMBL; M86376; AAA42272.1; -; Genomic_DNA.
DR   EMBL; M86373; AAA42272.1; JOINED; Genomic_DNA.
DR   EMBL; M86375; AAA42272.1; JOINED; Genomic_DNA.
DR   EMBL; J04035; AAA42268.1; -; mRNA.
DR   PIR; A36106; EART.
DR   RefSeq; NP_036854.1; NM_012722.1.
DR   AlphaFoldDB; Q99372; -.
DR   STRING; 10116.ENSRNOP00000045102; -.
DR   CarbonylDB; Q99372; -.
DR   PhosphoSitePlus; Q99372; -.
DR   jPOST; Q99372; -.
DR   PaxDb; 10116-ENSRNOP00000030301; -.
DR   DNASU; 25043; -.
DR   Ensembl; ENSRNOT00065001981; ENSRNOP00065001393; ENSRNOG00065001486. [Q99372-1]
DR   GeneID; 25043; -.
DR   KEGG; rno:25043; -.
DR   UCSC; RGD:67394; rat. [Q99372-1]
DR   AGR; RGD:67394; -.
DR   CTD; 2006; -.
DR   RGD; 67394; Eln.
DR   eggNOG; ENOG502RYNR; Eukaryota.
DR   InParanoid; Q99372; -.
DR   TreeFam; TF338594; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-1566948; Elastic fibre formation.
DR   Reactome; R-RNO-2129379; Molecules associated with elastic fibres.
DR   PRO; PR:Q99372; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0071953; C:elastic fiber; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0050840; F:extracellular matrix binding; ISO:RGD.
DR   GO; GO:0030023; F:extracellular matrix constituent conferring elasticity; IMP:RGD.
DR   GO; GO:0035904; P:aorta development; IEP:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; IDA:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071298; P:cellular response to L-ascorbic acid; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0048251; P:elastic fiber assembly; TAS:RGD.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; ISO:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0043149; P:stress fiber assembly; ISO:RGD.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; ELASTIN; 1.
DR   PANTHER; PTHR24018:SF5; ELASTIN; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Disulfide bond;
KW   Extracellular matrix; Hydroxylation; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000269|PubMed:26479776"
FT   CHAIN           28..870
FT                   /note="Elastin"
FT                   /id="PRO_0000021165"
FT   MOD_RES         39
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         75
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         87
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         105
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         122
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         126
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         207
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         220
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         223
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         244
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         290
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         309
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         338
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         360
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         363
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         375
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         402
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         408
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         413
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         418
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         434
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         438
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         441
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         485
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         488
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         518
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         539
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         554
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         558
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         615
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         619
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         623
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         637
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         646
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         662
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         670
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         677
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         680
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         715
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         730
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         734
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         793
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         796
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         842
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   DISULFID        860..865
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         269..313
FT                   /note="Missing (in isoform 2, isoform 5, isoform 7 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004244"
FT   VAR_SEQ         314
FT                   /note="Missing (in isoform 3, isoform 5, isoform 6 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004245"
FT   VAR_SEQ         815..829
FT                   /note="Missing (in isoform 4, isoform 6, isoform 7 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004246"
FT   CONFLICT        705
FT                   /note="F -> L (in Ref. 1; AAH85910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        713
FT                   /note="G -> GPGGLGG (in Ref. 1; AAH85910)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   870 AA;  73330 MW;  75909F2432FC4054 CRC64;
     MAGLTAAVPQ PGVLLILLLN LLHPAQPGGV PGAVPGGVPG GLPGGVPGGV YYPGAGIGGG
     LGGGALGPGG KPPKPGAGLL GAFGAGPGGL GGAGPGAGLS YASRPGGVLV PGGGAGAAAA
     YKAAAKAGAG LGGIGGVPGG VGVGGVPGAV GVGGVPGAVG GIGGIGGLGV STGAVVPQLG
     AGVGAGGKPG KVPGVGLPGV YPGGVLPGTG ARFPGVGVLP GVPTGTGVKA KVPGGGGGAF
     SGIPGVGPFG GQQPGVPLGY PIKAPKLPGG YGLPYTNGKL PYGVAGAGGK AGYPTGTGVG
     SQAAVAAAKA AKYAGAGGGG VLPGVGGGGI PGGAGAIPGI GGITGAGTPA AAAAAKAAAK
     AAKYGAAGGL VPGGPGVRVP GAGIPGVGIP GVGGIPGVGG IPGVGGIPGV GGPGIGGPGI
     VGGPGAVSPA AAAKAAAKAA KYGARGGVGI PTYGVGAGGF PGYGVGAGAG LGGASQAAAA
     AAAAKAAKYG AGGAGTLGGL VPGAVPGALP GAVPGALPGA VPGALPGAVP GVPGTGGVPG
     AGTPAAAAAA AAAKAAAKAG QYGLGPGVGG VPGGVGVGGL PGGVGPGGVT GIGTGPGTGL
     VPGDLGGAGT PAAAKSAAKA AAKAQYRAAA GLGAGVPGLG VGAGVPGFGA GAGGFGAGAG
     VPGFGAGAVP GSLAASKAAK YGAAGGLGGP GGLGGPGGLG GPGGFGGPGG LGGVPGGVAG
     GAPAAAAAAK AAAKAAQYGL GGAGGLGAGG LGAGGLGAGG LGAGGLGAGG LGAGGVIPGA
     VGLGGVSPAA AAKAAKYGAA GLGGVLGARP FPGGGVAARP GFGLSPIYPG GGAGGLGVGG
     KPPKPYGGAL GALGYQGGGC FGKSCGRKRK
//
